Nutex Health Overview
Latest P/E ratio for Nutex Health: 7.86 — see history and peer comparisons.
Get informed when a big investor buys or sells
+ Follow7.86
The P/E ratio compares a company's stock price to its earnings per share. A lower P/E ratio may indicate that the stock is undervalued.
The latest P/E ratio for NUTX is 7.86. That is below the Consumer Staples sector average of 12.44. Investors often review this figure alongside Nutex Health's historical trend and sector peers before judging valuation or financial health.
Against Consumer Staples companies, NUTX currently prints 7.86 for P/E ratio, while the sector average sits near 12.44. That is roughly 36.8% below the sector mean. Large gaps often invite a closer look at Nutex Health's growth, margins, and balance sheet.
A P/E ratio of 7.86 for Nutex Health is not 'good' or 'bad' on its own. Compare it with the peer average (12.44) and with NUTX's multi-year chart on this page. Persistently elevated multiples need growth or quality to justify them; depressed multiples need a catalyst or evidence the business is misunderstood.
After noting NUTX's P/E ratio (7.86), review year-over-year change, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.
This page's peer comparison chart is the fastest way to stack Nutex Health's P/E ratio against similar Consumer Staples names. You can also browse sector and industry screens on Stockcircle for a broader set of Consumer Staples companies and their key multiples and fundamentals.
